Exact Mass: 406.2104
Exact Mass Matches: 406.2104
Found 276 metabolites which its exact mass value is equals to given mass value 406.2104
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lincomycin
Lincomycin is only found in individuals that have used or taken this drug. It is an antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections. [PubChem]Lincomycin inhibits protein synthesis in susceptible bacteria by binding to the 50 S subunits of bacterial ribosomes and preventing peptide bond formation upon transcription. It is usually considered bacteriostatic, but may be bactericidal in high concentrations or when used against highly susceptible organisms. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FF - Lincosamides D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
Flurogestone Acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone Same as: D04235
Kiwiionoside
Kiwiionoside is found in fruits. Kiwiionoside is a constituent of Actinidia chinensis (kiwifruit). Constituent of Actinidia chinensis (kiwifruit). Kiwiionoside is found in fruits.
Argentine
Epilincomycin
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
Fluorogestone acetate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins
Panduratin A
Xanthoangelol F
Xanthoangelol f is a member of the class of compounds known as 3-prenylated chalcones. 3-prenylated chalcones are chalcones featuring a C5-isoprenoid unit at the 3-position. Thus, xanthoangelol f is considered to be a flavonoid lipid molecule. Xanthoangelol f is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Xanthoangelol f can be found in angelica, which makes xanthoangelol f a potential biomarker for the consumption of this food product.
2,6-Dihydroxy-3-(1-p-menthen-3-yl)-4-methoxychalcone
Heminitidulan
Adunctin C
N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(5-fluoropentyl)-3-(4-fluorophenyl)-1H-pyrazole-5-carboxamide
(+/-)-isopanduratin A1|4-(2,4-Dihydroxy-6-methoxybenzoyl)-1-methyl-5-phenyl-6-prenylcyclohexene
6-[10-(12,12-dimethyl-13alpha-(22-methyl-21-butenoyloxy)-16-methenylcyclohexyl)ethyl]-naphtalene-1,4-dione|cordiaquinone N
6-[10-(12,12-dimethyl-13alpha-(tigloyloxy)-16-methenylcyclohexyl)ethyl]-naphtalene-1,4-dione|cordiaquinone O
lespeflorin G5
A member of the class of pterocarpans that is (6aR,11aR)-pterocarpan substituted by hydroxy groups at positions 3 and 9, a methyl group at position 8 and prenyl groups at positions 4 and 10. Isolated from the roots of Lespedeza floribunda, it acts as a melanin synthesis inhibitor.
COc1ccc(C(=O)C=Cc2ccc(O)cc2)c(O)c1CC=C(/C)CCC=C(C)C
3,5,6-trihydroxydehydro-alpha-ionol 9-O-beta-D-glucopyranoside
Lincomycin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01F - Macrolides, lincosamides and streptogramins > J01FF - Lincosamides A carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic Origin: Microbe, Glycosides, Pyrrolidines CONFIDENCE standard compound; INTERNAL_ID 1180 CONFIDENCE standard compound; INTERNAL_ID 4105 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3687
Lincomycin aka '(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C19H34O9_beta-D-Glucopyranoside, 3,6-dihydroxy-3-[(1E)-3-hydroxy-1-buten-1-yl]-2,4,4-trimethylcyclohexyl
C19H34O9_2,4-Dihydroxy-4-[(1E)-3-hydroxy-1-buten-1-yl]-3,5,5-trimethylcyclohexyl beta-D-glucopyranoside
Ile Ser Ser Thr
Ile Ser Thr Ser
Ile Thr Ser Ser
Leu Ser Ser Thr
Leu Ser Thr Ser
Leu Thr Ser Ser
Ser Ile Ser Thr
Ser Ile Thr Ser
Ser Leu Ser Thr
Ser Leu Thr Ser
Ser Ser Ile Thr
Ser Ser Leu Thr
Ser Ser Thr Ile
Ser Ser Thr Leu
Ser Thr Ile Ser
Ser Thr Leu Ser
Ser Thr Ser Ile
Ser Thr Ser Leu
Ser Thr Thr Val
Ser Thr Val Thr
Ser Val Thr Thr
Thr Ile Ser Ser
Thr Leu Ser Ser
Thr Ser Ile Ser
Thr Ser Leu Ser
Thr Ser Ser Ile
Thr Ser Ser Leu
Thr Ser Thr Val
Thr Ser Val Thr
Thr Thr Ser Val
Thr Thr Val Ser
Thr Val Ser Thr
Thr Val Thr Ser
Val Ser Thr Thr
Val Thr Ser Thr
Val Thr Thr Ser
Kiwiionoside
CEHC glutamine
3-N-BOC-AMINO-3-(3-CBZ)PIPERIDINE-PROPIONICACIDETHYLESTER
Verucerfont
C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C2355 - Anti-Adrenal
1-N,4-N-bis(3,5-dimethylphenyl)-3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide
BMS-582949
1,2-bis(ethenyl)benzene,4-butoxy-4-oxobut-2-enoic acid,styrene
1-N,4-N-diphenyl-3,6-dipropyl-1,2,4,5-tetrazine-1,4-dicarboxamide
3,6-diethyl-1-N,4-N-bis(3-methylphenyl)-1,2,4,5-tetrazine-1,4-dicarboxamide
Tosedostat
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor D004791 - Enzyme Inhibitors
Samotolisib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C192218 - DNA-dependent Protein Kinase Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2201 - mTOR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor Samotolisib (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, DNA-PK and mTOR, respectively. Samotolisib potently inhibits mTORC1/2 at low nanomolar concentrations[1][2]. Samotolisib (LY3023414) potently and selectively inhibits class I PI3K isoforms, DNA-PK, and mTORC1/2 with IC50s of 6.07 nM, 77.6 nM, 38 nM, 23.8 nM, 4.24 nM and 165 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, DNA-PK and mTOR, respectively. Samotolisib potently inhibits mTORC1/2 at low nanomolar concentrations[1][2].
Panduratin A
(2S,4R)-N-[2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
11-(2-methylpropyl)-3-[2-(morpholin-4-yl)ethyl]-3,11-dihydro-4H-pyrimido[5,4:4,5]pyrrolo[2,3-b]quinoxalin-4-one
2-(hydroxymethyl)-6-[(E)-4-(1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl)but-3-en-2-yl]oxyoxane-3,4,5-triol
1-[4-(2-Fluorophenyl)-1-piperazinyl]-4-(4,4,6-trimethyl-2-sulfanylidene-1,3-diazinan-1-yl)-1-butanone
8-[11-(4-Methoxyphenyl)-1,8,12-triazatricyclo[7.3.0.03,7]dodeca-2,7,9,11-tetraen-2-yl]-1,4-dioxa-8-azaspiro[4.5]decane
5-Fluoro-1-[1-[[1-(2-phenylethyl)-5-tetrazolyl]methyl]-4-piperidinyl]benzotriazole
(E)-1-[4-hydroxy-2-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one
1-(2-fluorophenyl)-3-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
(5R,8S)-8-[(4-methoxyphenyl)methyl]-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(4R,7R)-4-[(4-methoxyphenyl)methyl]-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
1-(2-fluorophenyl)-3-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
1-(2-fluorophenyl)-3-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3,6-dihydro-2H-pyran-3-yl]urea
(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-phenyl-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-phenyl-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
(2-hydroxy-3-phosphonooxypropyl) (9Z,12Z)-hexadeca-9,12-dienoate
(2R,4S)-N-[2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
1-Palmitoleoyl-sn-glycerol 3-phosphate(2-)
A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmitoleoyl-sn-glycerol 3-phosphate
2-16:1-lysophosphatidate(2-)
A 2-acyl-sn-glycero-3-phosphate(2-) in which the acyl group is hexadecenoyl (position of double bond not specified).
1-Palmitoylglycerone 3-phosphate(2-)
An organophosphate oxoanion arising from deprotonation of the phosphate OH groups of 1-palmitoylglycerone 3-phosphate; major species at pH 7.3.
(2s,4r)-n-[(1s)-2-hydroxy-1-[(3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboximidic acid
1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4-dihydroxy-6-methoxyphenyl]-3-phenylprop-2-en-1-one
(1s,2s,3s,6r,7s,10r,11s,12r)-2-[5-(2h-1,3-benzodioxol-5-yl)pentyl]tetracyclo[8.2.1.0³,¹².0⁶,¹¹]trideca-4,8-diene-7-carboxylic acid
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2s,3e)-4-[(1r,2r,4r)-1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxane-3,4,5-triol
13-methyl-4,15-bis(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,14-diol
(2s)-5-hydroxy-6-[(1r,6r)-6-isopropyl-3-methylcyclohex-2-en-1-yl]-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r,3e)-4-[(1s,2s,4s)-1,2,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxane-3,4,5-triol
2-({4-[3,5-dihydroxy-2-(hydroxymethyl)-2,6-dimethylcyclohexyl]but-3-en-2-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol
6-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
5-methoxy-2-[(3r,8r)-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]phenol
5-methoxy-2-[(3s,8r)-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]phenol
(2r)-8-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydro-1-benzopyran-4-one
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-{[(2r)-4-[(1s,2r,3r,4s)-2,3,4-trihydroxy-2,6,6-trimethylcyclohexyl]but-3-en-2-yl]oxy}oxane-3,4,5-triol
5-methoxy-2-[(1s,6s)-4-(4-methylpent-3-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol
5-methoxy-2-[(1r,2r,6r)-3-methyl-2-(3-methylbut-2-en-1-yl)-6-phenylcyclohex-3-ene-1-carbonyl]benzene-1,3-diol
(2e)-1-{3-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-2,4-dihydroxy-6-methoxyphenyl}-3-phenylprop-2-en-1-one
1-{6-hydroxy-4'-isopropyl-4-methoxy-3h-spiro[1-benzofuran-2,1'-cyclohexan]-2'-en-7-yl}-3-phenylpropan-1-one
(1s,10s)-13-methyl-4,15-bis(3-methylbut-2-en-1-yl)-8,17-dioxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-2(7),3,5,11,13,15-hexaene-5,14-diol
1-(2,4-dihydroxyphenyl)-3-[4-methoxy-3,5-bis(3-methylbut-2-en-1-yl)phenyl]prop-2-en-1-one
2-{[4-(1,4-dihydroxy-2,2,6-trimethylcyclohexyl)-1-hydroxybut-3-en-2-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3s,5r,6r,7 e,9s)-megastigman-7-ene-3,5,6,9-tetrol-3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009650","Ingredient_name": "(3s,5r,6r,7 e,9s)-megastigman-7-ene-3,5,6,9-tetrol-3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C19H34O9","Ingredient_Smile": "CC(C=CC1(C(CC(CC1(C)O)OC2C(C(C(C(O2)CO)O)O)O)(C)C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13637","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3s,5r,6r,7 e,9s)-megastigman-7-ene-3,5,6,9-tetrol-9-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009651","Ingredient_name": "(3s,5r,6r,7 e,9s)-megastigman-7-ene-3,5,6,9-tetrol-9-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C19H34O9","Ingredient_Smile": "CC(C=CC1(C(CC(CC1(C)O)O)(C)C)O)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13638","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}